Applied Genetic Technologies Corporation (AGTC) Social Stream
APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering APPLIED GENETIC TECHNOLOGIES CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $35 | $8.001 | $16.714 | $0.394 | 4142.13% |
| 2021-11-10 | 7 | $35 | $8 | $16.571 | $0.394 | 4105.84% |
| 2022-01-11 | 7 | $35 | $8 | $16.142 | $0.394 | 3996.95% |
| 2022-02-09 | 7 | $35 | $8 | $15.285 | $0.394 | 3779.44% |
| 2022-02-15 | 7 | $35 | $8 | $16.166 | $0.394 | 4003.05% |
| 2022-05-02 | 7 | $35 | $8 | $15 | $0.394 | 3707.11% |
| 2022-05-17 | 7 | $35 | $6 | $14.428 | $0.394 | 3561.93% |
| 2022-05-18 | 7 | $35 | $5 | $14 | $0.394 | 3453.3% |
| 2022-08-18 | 4 | $24 | $2 | $9.6 | $0.394 | 2336.55% |
| 2022-09-28 | 5 | $24 | $2 | $9.6 | $0.394 | 2336.55% |
| 2022-09-30 | 6 | $16 | $2 | $6.2 | $0.394 | 1473.6% |
| 2022-10-04 | 6 | $16 | $0.5 | $4.9 | $0.394 | 1143.65% |
| 2022-10-25 | 5 | $0.4 | $0.34 | $0.36 | $0.394 | -8.63% |
| 2022-11-22 | 6 | $0.4 | $0.34 | $0.355 | $0.394 | -9.9% |
The Trend in the Analyst Price Target
Over the past 13 months, AGTC's average price target has gone down $16.36.
AGTC reports an average of 1,269.88% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-02 | 6 | 35.0 | 8.00 | 15.000 | 0.927 | 1518.12% |
| 2022-05-18 | 7 | 24.0 | 5.00 | 10.400 | 0.827 | 1157.56% |
| 2022-09-28 | 5 | 24.0 | 2.00 | 9.200 | 0.290 | 3072.41% |
| 2022-10-25 | 6 | 0.4 | 0.34 | 0.355 | 0.389 | -8.74% |
| 2022-11-22 | 6 | 0.4 | 0.34 | 0.355 | 0.368 | -3.53% |
AGTC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 6 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 52 weeks, AGTC's average broker recommendation rating worsened by 2.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, APPLIED GENETIC TECHNOLOGIES CORP's upside potential (average analyst target price relative to current price) is greater than 2193.91% of them.
- To contextualize these metrics, consider that out of all US stocks, APPLIED GENETIC TECHNOLOGIES CORP's variance in analysts' estimates is lower than -2129.12% of them.
- In the context of Healthcare stocks, APPLIED GENETIC TECHNOLOGIES CORP's average analyst price target is higher than 484.92% of them.
- APPLIED GENETIC TECHNOLOGIES CORP's number of analysts covering the stock is higher than 1924.18% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to APPLIED GENETIC TECHNOLOGIES CORP are CGEN, ONVO, and CRDF.
View All Top Stocks by Price Target
Is AGTC a Buy, Hold or Sell? See the POWR Ratings now!